[Efficacy of double-incision extracapsular cataract extraction in the treatment of hard-nucleus cataract with low corneal endothelial cell density].
Objective: To discuss the efficacy and safety of two-incision extracapsular cataract extraction (ECCE) in the treatment of hard-core cataract with corneal endothelial cell density is low. Methods: This study is a retrospective series of case studies. Forty-six patients (47 eyes) with hard-core cataract and corneal endothelial cell density are enrolled in Shandong Eye Hospital from June 2009 to December 2018, including 22 men and 24 women, aged 50 to 74 (63.8 ± 6, 3 years. Preoperative corneal endothelial cell density of less than 1000 cells / mm (2), and cataract nuclear force is equal to or greater than the fourth grade.
According to the method of surgery, patients were divided into single-incision ECCE group (24 eyes) and group ECCE two incisions (23 eyes). Surgical procedures for double-incision group is as follows. First, the pre-tops scleral incision is made. Then the conventional capsulorhexis is done through a transparent 2.6 mm corneal tunnel incision in the temporal or nasal side, after the hydro-dissection is done.
Next, the surgeon cuts a pre-incision in the sclera, lens nucleus delivered, sutured scleral incision and removed the residual cortical material from corneal incision. Finally, foldable intraocular lens implantation, and viscoelastic substance has been removed. The intraoperative conditions and postoperative anterior chamber corneal edema condition monitored. During 6 months of follow-up after surgery, endothelial cell density, visual acuity and astigmatism in the two groups were compared. The χ (2) test was used to compare the data calculation, and t test was used to compare measurement data.
Results: No difference was significant (t = P = group ECCE, which is (827 ± 164) cells / mm (2) and (802 ± 121) cells / mm (2), respectively At 6 months after surgery ,. in two incisions and single-incision group, the density of endothelial cells is (793 ± 147) cells / mm (2) and (706 ± 101) cells / mm (2), respectively, and the difference was statistically significant (t = P
Conclusion: The double-incision ECCE, in which the core is delivered through an incision scleral lenses and other procedures done through a corneal tunnel incision, safe and effective for patients of cataract with hard core and low corneal endothelial cell density
Endogenous structure ESX-3 secretion system.
ESX secretion system (or Type VII) is a protein export system in mycobacteria and many Gram-positive bacteria that mediate a variety of functions including virulence, conjugation, and regulation of metabolism.
This system translocate folded dimer WXG100-superfamily protein substrates across the cytoplasmic membrane. We report cryo-electron microscopy structure of the system of ESX-3, purified using epitope tag recombineering inserted in the chromosomes of a model organism Mycobacterium smegmatis.
Vimentin |
|||
AP88730 | SAB | 1mg | EUR 2640 |
Vimentin |
|||
AP88734 | SAB | 1mg | EUR 2640 |
Vimentin |
|||
AP88803 | SAB | 1mg | EUR 2640 |
Vimentin |
|||
AP89050 | SAB | 1mg | EUR 2640 |
Vimentin |
|||
AP89299 | SAB | 1mg | EUR 2640 |
Vimentin |
|||
AP78769 | SAB | 1mg | EUR 2640 |
Vimentin |
|||
ant-245 | ProSpec Tany | 0.5mg | EUR 275 |
Description: Mouse Anti Human Vimentin |
Vimentin |
|||
CH22108 | Neuromics | 100 ul | EUR 490.8 |
Vimentin |
|||
CH23010 | Neuromics | 100 ul | EUR 214.8 |
Vimentin |
|||
MA1102 | Antagene | 100μg | EUR 260 |
Vimentin |
|||
V1016 | Antagene | 0.2mg | EUR 180 |
Vimentin |
|||
MA1102-M | Antagene | 100μg | EUR 290 |
Description: Monoclonal Antibodies Conjugated to Magnetic Beads |
Vimentin |
|||
MA1102-S | Antagene | 100μg | EUR 290 |
Description: Monoclonal Antibodies Conjugated to Sepharose |
Vimentin |
|||
GWB-527FF1 | GenWay Biotech | 0.01 mg | Ask for price |
Vimentin |
|||
GT22103 | Neuromics | 100 ul | EUR 522 |
Vimentin |
|||
PR27081 | Neuromics | 20 ug | EUR 229.2 |
Vimentin |
|||
pro-309 | ProSpec Tany | 20µg | EUR 60 |
Description: Recombinant Human Vimentin |
Vimentin |
|||
MO22115 | Neuromics | 100 ul | EUR 490.8 |
Vimentin |
|||
MO22179 | Neuromics | 100 ug | EUR 522 |
Vimentin |
|||
MC-891 | Kamiya Biomedical Company | VI-RE/1 | Ask for price |
Vimentin |
|||
MC-892 | Kamiya Biomedical Company | V9 | Ask for price |
Vimentin |
|||
RA22124 | Neuromics | 100 ul of Serum | EUR 490.8 |
Vimentin |
|||
PR27081-B | Neuromics | each | EUR 184.5 |
Vimentin |
|||
MBS8534585-01mL | MyBiosource | 0.1mL | EUR 345 |
Vimentin |
|||
MBS8534585-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Vimentin |
|||
MBS8534585-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Vimentin |
|||
MBS8534585-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Vimentin |
|||
MBS8534585-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Vimentin |
|||
MBS8534714-01mL | MyBiosource | 0.1mL | EUR 345 |
Vimentin |
|||
MBS8534714-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Vimentin |
|||
MBS8534714-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Vimentin |
|||
MBS8534714-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Vimentin |
|||
MBS8534714-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Vimentin |
|||
MBS8533443-01mL | MyBiosource | 0.1mL | EUR 305 |
Vimentin |
|||
MBS8533443-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Vimentin |
|||
MBS8533443-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Vimentin |
|||
MBS8533443-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Vimentin |
|||
MBS8533443-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Vimentin |
|||
MBS8533952-01mL | MyBiosource | 0.1mL | EUR 345 |
Vimentin |
|||
MBS8533952-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Vimentin |
|||
MBS8533952-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Vimentin |
|||
MBS8533952-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Vimentin |
|||
MBS8533952-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Vimentin |
|||
MBS370116-01mLConcentrate | MyBiosource | 0.1mL(Concentrate) | EUR 225 |
Vimentin |
|||
MBS370116-05mLConcentrate | MyBiosource | 0.5mL(Concentrate) | EUR 375 |
Vimentin |
|||
MBS370116-15mLRTU | MyBiosource | 15mL(RTU) | EUR 425 |
Vimentin |
|||
MBS370116-3mLRTU | MyBiosource | 3mL(RTU) | EUR 215 |
Vimentin |
|||
MBS370116-7mLRTU | MyBiosource | 7mL(RTU) | EUR 270 |
Vimentin |
|||
MBS555398-01mL | MyBiosource | 0.1mL | EUR 410 |
Vimentin |
|||
MBS555398-5x01mL | MyBiosource | 5x0.1mL | EUR 1705 |
Vimentin |
|||
MBS555893-01mL | MyBiosource | 0.1mL | EUR 435 |
Vimentin |
|||
MBS555893-5x01mL | MyBiosource | 5x0.1mL | EUR 1815 |
Vimentin |
|||
MBS555941-01mg | MyBiosource | 0.1mg | EUR 435 |
Vimentin |
|||
MBS555941-5x01mg | MyBiosource | 5x0.1mg | EUR 1815 |
Vimentin |
|||
MBS556404-01mL | MyBiosource | 0.1mL | EUR 410 |
Vimentin |
|||
MBS556404-5x01mL | MyBiosource | 5x0.1mL | EUR 1705 |
Vimentin (VIM) |
|||
MBS6508456-002mL | MyBiosource | 0.02mL | EUR 435 |
Vimentin (VIM) |
|||
MBS6508456-01mL | MyBiosource | 0.1mL | EUR 715 |
Vimentin (VIM) |
|||
MBS6508456-5x01mL | MyBiosource | 5x0.1mL | EUR 3070 |
Vimentin FITC |
|||
ant-247 | ProSpec Tany | 0.5mg | EUR 350 |
Description: Mouse Anti Human Vimentin FITC |
Vimentin, Human |
|||
LF-P0388 | Abfrontier | 0.5 mg | EUR 363.6 |
Description: Vimentin, Human protein |
Human Vimentin |
|||
hAP-0952 | Angio Proteomie | 50ug | EUR 400 |
Human Vimentin |
|||
MBS691558-002mg | MyBiosource | 0.02mg | EUR 300 |
Human Vimentin |
|||
MBS691558-01mg | MyBiosource | 0.1mg | EUR 450 |
Human Vimentin |
|||
MBS691558-5x01mg | MyBiosource | 5x0.1mg | EUR 1725 |
Vimentin ELISA |
|||
MBS494838-5x96Tests | MyBiosource | 5x96Tests | EUR 3110 |
Vimentin ELISA |
|||
MBS494838-96Tests | MyBiosource | 96Tests | EUR 680 |
Vimentin Biotin |
|||
ant-246 | ProSpec Tany | 0.5mg | EUR 350 |
Description: Mouse Anti Human Vimentin Biotinylated |
Bovine Vimentin |
|||
7-06862 | CHI Scientific | 2µg | Ask for price |
Bovine Vimentin |
|||
7-06863 | CHI Scientific | 10µg | Ask for price |
Bovine Vimentin |
|||
7-06864 | CHI Scientific | 1mg | Ask for price |
Bovine Vimentin |
|||
rAP-5064 | Angio Proteomie | Inquiry | Ask for price |
Bovine Vimentin |
|||
MBS143077-0002mg | MyBiosource | 0.002mg | EUR 240 |
Bovine Vimentin |
|||
MBS143077-001mg | MyBiosource | 0.01mg | EUR 310 |
Bovine Vimentin |
|||
MBS143077-1mg | MyBiosource | 1mg | EUR 3770 |
Bovine Vimentin |
|||
MBS143077-5x1mg | MyBiosource | 5x1mg | EUR 16645 |
Vimentin protein |
|||
30R-AV009 | Fitzgerald | 100 ug | EUR 1539 |
Description: Purified recombinant Human Vimentin protein |
Vimentin protein |
|||
30R-2114 | Fitzgerald | 250 ug | EUR 1228 |
Description: Purified native Bovine Vimentin protein |
Vimentin protein |
|||
30R-2134 | Fitzgerald | 100 ug | EUR 755 |
Description: Purified native Bovine Vimentin Protein |
Vimentin protein |
|||
30R-2137 | Fitzgerald | 100 ug | EUR 649 |
Description: Purified recombinant Human Vimentin protein |
Vimentin Peptide |
|||
43-649P | ProSci | 0.1 mg | EUR 405.6 |
Vimentin Protein |
|||
20-abx263566 | Abbexa |
|
|
Vimentin Protein |
|||
20-abx260337 | Abbexa |
|
|
Vimentin Protein |
|||
abx260337-20g | Abbexa | 20 µg | EUR 325 |
Vimentin Protein |
|||
abx260337-5g | Abbexa | 5 µg | EUR 225 |
Vimentin protein |
|||
MBS836953-01mg | MyBiosource | 0.1mg | EUR 1045 |
Vimentin protein |
|||
MBS836953-5x01mg | MyBiosource | 5x0.1mg | EUR 4560 |
Vimentin protein |
|||
MBS537604-01mg | MyBiosource | 0.1mg | EUR 920 |
Vimentin protein |
|||
MBS537604-025mg | MyBiosource | 0.25mg | EUR 1850 |
Vimentin protein |
|||
MBS537604-5x025mg | MyBiosource | 5x0.25mg | EUR 8175 |
Vimentin protein |
|||
MBS536597-025mg | MyBiosource | 0.25mg | EUR 1920 |
Vimentin protein |
|||
MBS536597-5x025mg | MyBiosource | 5x0.25mg | EUR 8495 |
Vimentin protein |
|||
MBS536607-01mg | MyBiosource | 0.1mg | EUR 950 |
Vimentin protein |
|||
MBS536607-5x01mg | MyBiosource | 5x0.1mg | EUR 4115 |
Vimentin Antibody |
|||
8C0390 | AAT Bioquest | 50ug | EUR 368 |
Description: Vimentin Antibody |
Vimentin antibody |
|||
10R-V104a | Fitzgerald | 50 ug | EUR 492 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-8124 | Fitzgerald | 100 ug | EUR 557 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-8125 | Fitzgerald | 100 ug | EUR 626 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-8126 | Fitzgerald | 100 ug | EUR 462 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-8545 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-8546 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-8547 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-10357 | Fitzgerald | 100 ug | EUR 451 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-1903 | Fitzgerald | 100 ul | EUR 468 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-2081 | Fitzgerald | 100 ul | EUR 503 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-2386 | Fitzgerald | 5 mL | EUR 306 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-2434 | Fitzgerald | 5 mL | EUR 468 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-7803 | Fitzgerald | 500 ug | EUR 678 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
10R-7911 | Fitzgerald | 100 ug | EUR 519 |
Description: Mouse monoclonal Vimentin antibody |
Vimentin antibody |
|||
20R-2697 | Fitzgerald | 50 ug | EUR 269 |
Description: Rabbit polyclonal Vimentin antibody |
Vimentin antibody |
|||
20R-2962 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Rabbit polyclonal Vimentin antibody |
Vimentin antibody |
|||
20R-VP004 | Fitzgerald | 100 uL | EUR 565 |
Description: Guinea Pig polyclonal Vimentin antibody |
Vimentin Antibody |
|||
21488 | SAB | 100ul | EUR 319 |
Vimentin Antibody |
|||
21488-100ul | SAB | 100ul | EUR 302.4 |
Vimentin Antibody |
|||
21488-50ul | SAB | 50ul | EUR 224.4 |
Vimentin antibody |
|||
20C-CR2052G | Fitzgerald | 250 ul | EUR 392 |
Description: Goat polyclonal Vimentin antibody |
Vimentin antibody |
|||
20R-1397 | Fitzgerald | 10 mg | EUR 276 |
Description: Sheep polyclonal Vimentin antibody |
Vimentin antibody |
|||
20R-1681 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal Vimentin antibody |
Vimentin Antibody |
|||
33541-100ul | SAB | 100ul | EUR 302.4 |
Vimentin Antibody |
|||
33541-50ul | SAB | 50ul | EUR 224.4 |
Vimentin Antibody |
|||
3634-100 | Biovision | each | EUR 405.6 |
Vimentin Antibody |
|||
3634-30T | Biovision | each | EUR 175.2 |
Vimentin Antibody |
|||
48952 | SAB | 100ul | EUR 499 |
Vimentin Antibody |
|||
48952-100ul | SAB | 100ul | EUR 399.6 |
Vimentin Antibody |
|||
48952-50ul | SAB | 50ul | EUR 286.8 |
Vimentin Antibody |
|||
E033541 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E021488 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E10-20118 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E11-0390C | EnoGene | 100μg | EUR 225 |
Description: Available in various conjugation types. |
VIMENTIN Antibody |
|||
E10-20301 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E18-6131-1 | EnoGene | 50μg/50μl | EUR 145 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E18-6131-2 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E18-0292-1 | EnoGene | 50μg/50μl | EUR 145 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E18-0292-2 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E18-7013-1 | EnoGene | 50μg/50μl | EUR 145 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E18-7013-2 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E76026 | EnoGene | 100μl | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E8EM0401 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
DF7035 | Affbiotech | 200ul | EUR 420 |
Vimentin Antibody |
|||
DF7052 | Affbiotech | 200ul | EUR 420 |
Vimentin Antibody |
|||
DF7052-100ul | Affinity Biosciences | 100ul | EUR 280 |
Vimentin Antibody |
|||
DF7052-200ul | Affinity Biosciences | 200ul | EUR 350 |
Vimentin Antibody |
|||
E38PA5808 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E38PA9220 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E38PA9746 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E551112-3-PU | EnoGene | 100ug | EUR 295 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E38PA2228 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E301327 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
Vimentin Antibody |
|||
E2220012 | EnoGene | 100ug | EUR 225 |
Description: Available in various conjugation types. |
Vimentin PAT5H8AT |
|||
ant-682 | ProSpec Tany | 5µg | EUR 60 |
Description: Mouse Anti Human Vimentin AT5H8 |
Vimentin antibody |
|||
CAF50631-100ug | Biomatik Corporation | 100ug | EUR 338 |
Vimentin antibody |
|||
70R-10611 | Fitzgerald | 500 ug | EUR 532 |
Description: Affinity purified sheep polyclonal Vimentin antibody |
Vimentin antibody |
|||
70R-11961 | Fitzgerald | 100 ug | EUR 371 |
Description: Rabbit polyclonal Vimentin antibody |
Vimentin antibody |
|||
70R-2952 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal Vimentin antibody raised against the C terminal of VIM |
Vimentin antibody |
|||
70R-3030 | Fitzgerald | 50 ug | EUR 467 |
Description: Rabbit polyclonal Vimentin antibody raised against the N terminal of VIM |
Vimentin antibody |
|||
70R-30831 | Fitzgerald | 100 ug | EUR 294 |
Description: Rabbit polyclonal Vimentin antibody |
Vimentin antibody |
|||
70R-35997 | Fitzgerald | 100 ug | EUR 294 |
Description: Rabbit polyclonal Vimentin antibody |
Vimentin antibody |
|||
70R-36156 | Fitzgerald | 100 ug | EUR 294 |
Description: Rabbit polyclonal Vimentin antibody |
Vimentin antibody |
|||
70R-50546 | Fitzgerald | 100 ul | EUR 286 |
Description: Purified Polyclonal Vimentin antibody |
Vimentin antibody |
|||
70R-50547 | Fitzgerald | 100 ul | EUR 242 |
Description: Purified Polyclonal Vimentin antibody |
Vimentin Antibody |
|||
AF0292 | Affbiotech | 200ul | EUR 420 |
Vimentin Antibody |
|||
AF6131 | Affbiotech | 200ul | EUR 420 |
Vimentin Antibody |
|||
AF7712 | Affbiotech | 200ul | EUR 540 |
Vimentin Antibody |
|||
AF7712-100ul | Affinity Biosciences | 100ul | EUR 350 |
Vimentin Antibody |
|||
AF7712-200ul | Affinity Biosciences | 200ul | EUR 450 |
Vimentin Antibody |
|||
AF7712-50ul | Affinity Biosciences | 50ul | EUR 250 |
Vimentin Antibody |
|||
AF7013 | Affbiotech | 200ul | EUR 540 |
Vimentin Antibody |
|||
AF7013-100ul | Affinity Biosciences | 100ul | EUR 350 |
Vimentin Antibody |
|||
AF7013-200ul | Affinity Biosciences | 200ul | EUR 450 |
Vimentin Antibody |
|||
AF7013-50ul | Affinity Biosciences | 50ul | EUR 250 |
Vimentin Antibody |
|||
ABF0292 | Nova Lifetech | 100ug | EUR 325 |
Vimentin Antibody |
|||
ABF6131 | Nova Lifetech | 100ug | EUR 325 |
Vimentin Antibody |
|||
ABF7013 | Nova Lifetech | 100ug | EUR 325 |
Vimentin Antibody |
|||
F48161-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Along with the microfilaments (actins) and microtubules (tubulins), the intermediate filaments represent a third class of well-characterized cytoskeletal elements. The subunits display a tissue-specific pattern of expression. Desmin is the subunit specific for muscle and vimentin the subunit specific for mesenchymal tissue. |
Vimentin Antibody |
|||
F48161-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 330.65 |
Description: Along with the microfilaments (actins) and microtubules (tubulins), the intermediate filaments represent a third class of well-characterized cytoskeletal elements. The subunits display a tissue-specific pattern of expression. Desmin is the subunit specific for muscle and vimentin the subunit specific for mesenchymal tissue. |
Vimentin Antibody |
|||
F48162-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Along with the microfilaments (actins) and microtubules (tubulins), the intermediate filaments represent a third class of well-characterized cytoskeletal elements. The subunits display a tissue-specific pattern of expression. Desmin is the subunit specific for muscle and vimentin the subunit specific for mesenchymal tissue. |
Vimentin Antibody |
|||
F48162-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: Along with the microfilaments (actins) and microtubules (tubulins), the intermediate filaments represent a third class of well-characterized cytoskeletal elements. The subunits display a tissue-specific pattern of expression. Desmin is the subunit specific for muscle and vimentin the subunit specific for mesenchymal tissue. |
Vimentin Antibody |
|||
F48163-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally. It is involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. [UniProt] |
Vimentin Antibody |
|||
F54035-0.1ML | NSJ Bioreagents | 0.1 ml | EUR 322.15 |
Description: Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally. |
Vimentin Antibody |
|||
F52051-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: This gene encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in this gene causes a dominant, pulverulent cataract. |
Vimentin Antibody |
|||
F52051-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 330.65 |
Description: This gene encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in this gene causes a dominant, pulverulent cataract. |
Vimentin Antibody |
|||
GWB-61859C | GenWay Biotech | 0.5 ml | Ask for price |
Vimentin, Antibody |
|||
GWB-656E3C | GenWay Biotech | 1 ml | Ask for price |
Vimentin, Antibody |
|||
GWB-2439B6 | GenWay Biotech | 0.1 mg | Ask for price |
The structure reveals stacked architecture that extends above and below the membrane in bacteria. ESX-3 protomer complex assembled from a single copy of EccB3, EccC3, and EccE3 and two copies of the proteins EccD3. In the structure, protomers form a stable dimer that is consistent with the assembling into larger oligomers. ESX-3 structure provides a framework for further study of this important bacterial transporter.
No Comment